Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

Bcr-abl-positive cells secrete angiogenic factors including matrix metalloproteinases and stimulate angiogenesis in vivo in Matrigel implants

Leukemia volume 16, pages 1160–1166 (2002)Cite this article

Abstract

To further elucidate the role of angiogenesis in the pathogenesis of chronic myelogenous leukemia (CML) we evaluated the effects of the bcr-abl translocation on the secretion of the angiogenic factors VEGF, FGF-2, HGF, IL-8 and matrix metalloproteinases (MMPs) as well as on the angiogenic potential in vivo of bcr-abl+ cells. First, we examined murine FL5.12 cells transfected with the bcr-abl constructs p185, p210 and p230 and found that the transfected cells secreted as much as four-fold more VEGF (p185 > p210 >p230) than wild-type (wt) cells, as well as MMP-9 and MMP-2. When Matrigel fragments containing these bcr-abl+ cells were implanted subcutaneously in SCID or Balb-C mice they became significantly more vascularized and hemoglobinized than implants containing normal or wt cells (p185 > p210 > p230). Similarly, we found that myeloblasts expanded from bone marrow (BM) CD34+ cells derived from Philadelphia-positive CML patients secreted up to 10 times more VEGF, FGF-2, HGF and IL-8 compared to myeloblasts derived from normal donors’ BM CD34+ cells and that BM mononuclear cells (MNC) isolated from CML patients induced vascularization of Matrigel implants in mice. Moreover, we found that peripheral blood MNC expressed MMP-2 and membrane-type (MT)1-MMP in about 50% of CML patients studied, and MMP-9 in all of them. Furthermore, VEGF stimulated the secretion of MMP-9 in these primary CML cells. We conclude that stimulation of angiogenesis by angiogenic factors, including MMPs, could play an important role in the pathogenesis of CML, suggesting that therapies targeting the newly formed endothelium could be developed for CML.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Folkman J . How is blood vessel growth regulated in normal and neoplastic tissue? Cancer Res 1986 46: 467–473

    CAS  PubMed  Google Scholar 

  2. Folkman J, D'Amore PA . Blood vessel formation: what is its molecular basis? Cell 1996 87: 1153–1155

    Article  CAS  PubMed  Google Scholar 

  3. Perez-Atayde AR, Sallan SE, Tedrow U, Connors S, Allred E, Folkman J . Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia Am J Pathol 1997 150: 815–821

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Padro T, Ruiz S, Bieker R, Burger H, Steins M, Kienast J, Buchner T, Berdel WE, Mesters RM . Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia Blood 2000 95: 2637–2644

    CAS  PubMed  Google Scholar 

  5. Chen H, Treweeke AT, West DC, Till KJ, Cawley JC, Zuzel M, Toh CH . In vitro and in vivo production of vascular endothelial growth factor by chronic lymphocytic leukemia cells Blood 2000 96: 3181–3187

    CAS  PubMed  Google Scholar 

  6. Vacca A, Ribatti D, Presta M, Minischetti M, Iurlaro M, Ria R, Albini A, Bussolino F, Dammacco F . Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma Blood 1999 93: 3064–3073

    CAS  PubMed  Google Scholar 

  7. Di Raimondo F, Azzaro MP, Palumbo GA, Bagnato S, Giustolisi G, Floridia PM, Sortino G, Giustolisi R . Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood Haematologica 2000 85: 800–805

    CAS  PubMed  Google Scholar 

  8. Pruneri G, Bertolini F, Soligo D, Carboni N, Cortelezzi A, Ferrucci PF, Buffa R, Lambertenghi-Deliliers G, Pezzella F . Angiogenesis in myelodysplastic syndromes Br J Cancer 1999 81: 1398–1401

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Aguayo A, Kantarijan H, Manshouri T, Gidel C, Estey E, Thomas D, Koller C, Estrov Z, O'Brien S, Keating M, Freireich E, Albitar M . Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes Blood 2000 96: 2240–2245

    CAS  PubMed  Google Scholar 

  10. Rafii S, Mohle R, Shapiro F, Frey BM, Moore MAS . Regulation of hematopoiesis by microvascular endothelium Leuk Lymphoma 1997 27: 375–386

    Article  CAS  PubMed  Google Scholar 

  11. Bertolini F, Manusco P, Gobbi A, Pruneri G . The thin red line: angiogenesis in normal and malignant hematopoiesis Exp Hematol 2000 28: 993–1000

    Article  CAS  PubMed  Google Scholar 

  12. Ratajczak MZ, Ratajczak J, Machalinski B, Majka M, Marlicz W, Carter A, Pietrzkowski Z, Gewirtz AM . Role of vascular endothelial growth factor (VEGF), placenta derived growth factor (PlGF)/Flt-1 and Flk-1/KDR receptor axes in human adult and fetal hematopoiesis Br J Haematol 1998 103: 969–979

    Article  CAS  PubMed  Google Scholar 

  13. Lundberg LG, Lerner R, Sundelin P, Rogers R, Folkman J, Palmbald J . Bone marrow in polycythemia vera, chronic myelocytic leukemia, and myelofibrosis has an increased vascularity Am J Pathol 2000 157: 15–19

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Stetler-Stevenson WG . Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention J Clin Invest 1999 103: 1237–1241

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Stetler-Stevenson WG, Hewitt R, Corcoran M . Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic Semin Cancer Biol 1996 7: 147–154

    Article  CAS  PubMed  Google Scholar 

  16. Janowska-Wieczorek A, Marquez LA, Nabholtz J-M, Cabuhat ML, Montaæo J, Chang H, Rozmus J, Russell JA, Edwards DR, Turner AR . Growth factors and cytokines upregulate gelatinase expression in bone marrow CD34+ cells and their transmigration through reconstituted basement membrane Blood 1999 93: 3379–3390

    CAS  PubMed  Google Scholar 

  17. Janowska-Wieczorek A, Marquez LA, Matsuzaki A, Hashmi HR, Larratt LM, Boshkov LM, Turner AR, Zhang MC, Edwards DR, Kossakowska AE . Expression of matrix metalloproteinases (MMP-2 and -9) and tissue inhibitors of metalloproteinases (TIMP-1 and-2) in acute myelogenous leukaemia blasts: comparison with normal bone marrow cells Br J Haematol 1999 105: 402–411

    Article  CAS  PubMed  Google Scholar 

  18. Matsuzaki A, Janowska-Wieczorek A . Unstimulated human acute myelogenous leukemia blasts secrete matrix metalloproteinases J Cancer Res Clin Oncol 1997 123: 100–106

    Article  CAS  PubMed  Google Scholar 

  19. Kossakowska AE, Edwards DR, Prusinkiewicz C, Zhang MC, Guo D, Urbanski SJ, Grogan T, Marquez LA, Janowska-Wieczorek A . Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin's lymphomas Blood 1999 94: 2080–2089

    CAS  PubMed  Google Scholar 

  20. Marquez-Curtis LA, Dobrowsky A, Montaæo J, Turner AR, Ratajczak J, Ratajczak MZ, Janowska-Wieczorek A . Matrix metalloproteinase and tissue inhibitors of metalloproteinase secretion by haematopoietic and stromal precursors and their production in normal and leukaemic long-term marrow cultures Br J Haematol 2001 115: 595–604

    Article  CAS  PubMed  Google Scholar 

  21. Deininger MWN, Goldman JM, Melo JV . The molecular biology of chronic myeloid leukemia Blood 2000 96: 3343–3657

    CAS  PubMed  Google Scholar 

  22. Sattler M, Salgia R . Activation of hematopoietic growth factor signal transduction pathways by the human oncogene BCR/ABL Cytok Growth Factor Rev 1997 8: 63–79

    Article  CAS  Google Scholar 

  23. Faderl S, Talpaz M, Estrov Z, O,Brien S, Kurzrock R, Kantarijan HM . The biology of chronic myeloid leukemia N Engl J Med 1999 341: 164–171

    Article  CAS  PubMed  Google Scholar 

  24. Melo JV . The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype Blood 1996 88: 2375–2384

    CAS  PubMed  Google Scholar 

  25. McKearn JP, McCubrey J, Fagg B . Enrichment of hematopoietic precursor cells and cloning of multipotential B-lymphocyte precursors Proc Natl Acad Sci USA 1985 82: 7414–7418

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Pear WS, Cepko C . Transduction of genes using retrovirus vectors In:, Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K (eds) Current Protocols in Molecular Biology, Supplement 36 Wiley: New York, NY 1996 p 99.1

    Google Scholar 

  27. Quackenbush RC, Reuther GW, Miller JP, Courtney KD, Pear WS, Pendergast AM . Analysis of the biologic properties of p230 bcr-abl reveals unique and overlapping properties with the oncogenic p185 and p210 bcr-abl tyrosine kinases Blood 2000 95: 2913–2921

    CAS  PubMed  Google Scholar 

  28. Pear WS, Miller JP, Xu L, Pui JC, Soffer B, Quackenbush RC, Pendergast AM, Bronson R, Aster JC, Scott ML, Baltimore D . Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow Blood 1998 92: 3780–3792

    CAS  PubMed  Google Scholar 

  29. Majka M, Janowska-Wieczorek A, Ratajczak J, Ehrenman K, Kowalska MA, Gewirtz AM, Emerson SG, Ratajczak MZ . Numerous growth factors, cytokines and chemokines are secreted by human CD34+ cells, myeloblasts, erythroblasts and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner Blood 2001 97: 3075–3085

    Article  CAS  PubMed  Google Scholar 

  30. Majka M, Janowska-Wieczorek A, Ratajczak J, Kowalska MA, Vilaire G, Pan ZK, Honczarenko M, Marquez LA, Poncz M, Ratajczak MZ . Stromal derived factor-1 and thrombopoietin regulate distinct aspects of human megakaryopoiesis Blood 2000 96: 4142–4151

    CAS  PubMed  Google Scholar 

  31. Majka M, Rozmyslowicz T, Lee B, Pietrzkowski Z, Gaulton GN, Silberstein L, Ratajczak MZ . Bone marrow CD34+ cells and megakaryoblasts secrete β-chemokines; implications for infectability by M-tropic human immunodeficiency virus (R5 HIV) J Clin Invest 1999 104: 1739–1749

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Janowska-Wieczorek A, Marquez LA, Dobrowsky A, Ratajczak MZ, Cabuhat ML . Differential MMP and TIMP production by human marrow and peripheral blood CD34+ cells in response to chemokines Exp Hematol 2000 28: 1274–1285

    Article  CAS  PubMed  Google Scholar 

  33. Wong H, Anderson WD, Cheng T, Riabowol KT . Monitoring mRNA expression by polymerase chain reaction: the ’primer-dropping’ method Anal Biochem 1994 223: 251–258

    Article  CAS  PubMed  Google Scholar 

  34. Coughlin CM, Salhany KE, Wysocka M, Aruga E, Kurzawa H, Chang AE, Hunter CA, Fow JC, Trinchieri G, Lee WMF . Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis J Clin Invest 1998 101: 1441–1452

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Coughlin CM, Salhany KE, Gee MS, LaTemple DC, Kotenko S, Ma X, Gri G, Wysocka M, Kim JE, Liu L, Liao F, Farber JM, Pestka S, Trinchieri G, Lee WMF . Tumor cell responses to IFNγ affect tumorigenicity and responses to IL-12 therapy and antiangiogenesis Immunity 1998 9: 25–34

    Article  CAS  PubMed  Google Scholar 

  36. Donato NJ, Wu JY, Zhang L, Kantarjian H, Talpaz M . Down-regulation of interleukin-3/granulocyte–macrophage colony stimulating factor receptor beta-chain in bcr-abl+ human leukemic cells: association with loss of cytokine-mediated Stat-5 activation and protection from apoptosis after bcr-abl inhibition Blood 2001 97: 2846–2853

    Article  CAS  PubMed  Google Scholar 

  37. Bhatia R, Munthe HA, Verfaillie CM . Tyrophostin AG957, a tyrosine kinase inhibitor with anti-bcr/abl tyrosine kinase activity restores beta1 integrin-mediated adhesion and inhibitory signaling in chronic myelogenous leukemia hematopoietic progenitors Leukemia 1998 12: 1708–1717

    Article  CAS  PubMed  Google Scholar 

  38. Deutsch E, Dugray A, Abdul Karim B, Marangoni F, Maggiorella L, Vaganay S, M'Kacher M, Rasy SD, Eschwege F, Vainchenker W, Turhan AG, Bourhis J . Bcr-abl down-regulates the DNA repair protein DNA-PKcs Blood 2001 97: 2084–2090

    Article  CAS  PubMed  Google Scholar 

  39. Li S, Ilaria RL, Million RP, Daley GQ, VanEtten RA . The p190, P210, and P230 forms of BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity J Exp Med 1999 189: 1399–1412

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Lamoreaux WJ, Fitzgerald MEC, Reiner A, Hasty KA, Charles ST . Vascular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitro Microvascular Res 1998 55: 29–42

    Article  CAS  Google Scholar 

  41. Dias S, Hattori K, Zhu Z, Heissig B, Choy M, Lane W, Wu Y, Chadburn A, Hyjek E, Gill M, Hicklin DJ, Witte L, Moore MAS, Rafii S . Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration J Clin Invest 2000 106: 511–521

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Itoh T, Tanioka M, Yoshida H, Yoshioka T, Nishimoto H, Itohara S . Reduced angiogenesis and tumor progression in gelatinase A-deficient mice Cancer Res 1998 58: 1048–1051

    CAS  PubMed  Google Scholar 

  43. Puyraimond A, Weitzman JB, Babiole E, Menashi S . Examining the relationship between the gelatinolytic balance and the invasive capacity of endothelial cells J Cell Sci 1999 112: 1283–1290

    CAS  PubMed  Google Scholar 

  44. Murphy AN, Unsworth EJ, Stetler-Stevenson WG . Tissue inhibitor of metalloproteinase-2 inhibits bFGF-induced human microvascular endothelial cell proliferation J Cell Physiol 1993 157: 351–358

    Article  CAS  PubMed  Google Scholar 

  45. Taraboletti G, Garofalo A, Belotti D, Drudis T, Borsotti P, Scanziani E, Brown PD, Giavazzi R . Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases J Natl Cancer Inst 1995 87: 293–298

    Article  CAS  PubMed  Google Scholar 

  46. Ries C, Loher F, Zang C, Ismair MG, Petrides PE . Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes Clin Cancer Res 1999 5: 1115–1124

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Supported by NIH grant R01 HL61796–01 to MZR and Canadian Blood Services R & D grant to AJ-W.

Author information

Authors and Affiliations

  1. Stem Cell Biology Program at James Graham Brown Cancer Center University of Louisville, Louisville, KY, USA

    M Majka & MZ Ratajczak

  2. Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA

    JA Wertheim

  3. Department of Medicine, University of Alberta, Edmonton, Alberta, Canada

    A Janowska-Wieczorek & AR Turner

  4. Canadian Blood Services, Edmonton, Alberta, Canada

    A Janowska-Wieczorek & L Marquez-Curtis

Authors
  1. A Janowska-Wieczorek
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M Majka
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L Marquez-Curtis
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. JA Wertheim
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. AR Turner
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. MZ Ratajczak
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Janowska-Wieczorek, A., Majka, M., Marquez-Curtis, L. et al. Bcr-abl-positive cells secrete angiogenic factors including matrix metalloproteinases and stimulate angiogenesis in vivo in Matrigel implants. Leukemia 16, 1160–1166 (2002). https://doi.org/10.1038/sj.leu.2402486

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402486

Keywords

This article is cited by

Search

Advanced search

Quick links